Skip to main content
Caplight Logo









Defibrio AS

Defibrio AS

Private
Arlington, MassachusettsHealthcare & Life Scienceshttps://defibrio.com/

Last Round

VC Round

Jun 18, 2025

Total Funding Raised

$12.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Defibrio AS is a healthtech company that develops smartphone-powered automated external defibrillators (AEDs) designed to provide accessible and cost-effective emergency cardiac care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

AEDautomated external defibrillatorpersonal defibrillatormedtechsmartphone-powered medical devicecardiac arrest emergencyrhythm-recognition algorithmmHealthmobile health appportable medical devicehealth IoTemergency preparednessrazor and blade modelconsumer medical techhome safety device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Defibrio AS Comparables

Compare Defibrio AS with similar companies based on industry and business-model similarity.

Defibrio AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HeartHero, Inc.
84%
Rapid Response Revival Research Limited
82%
Avive
74%

Defibrio AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 18, 2025
SeedMar 1, 2022

Key People

Founding team and executive leadership

Josh Hale

Chief Product Officer

Executive Team

Defibrio AS Investors

Notable investors and investment history

Defibrio AS investors
InvestorRounds
Rieber & SønVC Round
KistefosVC Round
ProVentureVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 32% MoM.

  • Jun 25, 2026

    Monthly visitors grew 292% MoM, reaching 2.2K.

Defibrio AS Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Defibrio AS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Defibrio AS's valuation, stock price, and market status.

Firmographic Details

HeadquartersArlington, Massachusetts
Employee Range6
Year Founded2020
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?